316 results on '"Longo, Christopher"'
Search Results
2. Relationship between income and concerns about physical changes and help-seeking by older adult cancer survivors: a secondary analysis
3. Exploring the relationships between income and emotional/practical concerns and help-seeking by older adult cancer survivors: A secondary analysis
4. Is vaccine hesitancy justified? Benchmarking post-market vaccine risks with five commonly used medicinal products in Canada
5. Experiencing financial toxicity associated with cancer in publicly funded healthcare systems: a systematic review of qualitative studies
6. Unrecognized assets created by public-sector investments in health and social services
7. Emerging Understanding About the Impact of Financial Toxicity Related to Cancer: Canadian Perspectives
8. Patient and family financial burden associated with cancer treatment in Canada: a national study
9. Designing Inquiry-Oriented Science Lab Activities
10. Financial toxicity associated with a cancer diagnosis in publicly funded healthcare countries: a systematic review
11. When are Pharmaceuticals Priced Fairly? An Alternative Risk-Sharing Model for Pharmaceutical Pricing
12. Pragmatic pharmacoeconomic analyses by using post-market adverse drug reaction reports: an illustration using infliximab, adalimumab, and the Canada vigilance adverse reaction database
13. The Economic Burden of Bladder Cancer Due to Occupational Exposure
14. Elective Repeat Caesarean Section in Low-Risk Women—Economic Evaluation Comparing Births Before vs. After 39 Weeks Gestation in Ontario, Canada
15. Patient and Family Financial Burden in Cancer: A Focus on Differences across Four Provinces, and Reduced Spending Including Decisions to Forego Care in Canada.
16. Choices of Methodology in Pharmacoeconomic Studies
17. Changing the Instructional Model: Utilizing Blended Learning as a Tool of Inquiry Instruction in Middle School Science
18. Societal Perspectives and Real-World Cost-Effectiveness: Expanding the Scope of Health Economics Inquiry
19. Longitudinal Assessment of Labor Market Earnings Among Patients Diagnosed With Cancer in Canada
20. How to Inform Vaccine Hesitant Individuals about the Potential Risks Associated with Vaccination
21. Impact of Income on Physical Concerns, Help Seeking, and Unmet Needs of Adult Cancer Survivors.
22. Understanding the full breadth of cancer-related patient costs in Ontario: a qualitative exploration
23. Effectiveness of Health System Services and Programs for Youth to Adult Transitions in Mental Health Care: A Systematic Review of Academic Literature
24. Effects of an Inquiry-Based Science Program on Critical Thinking, Science Process Skills, Creativity, and Science Fair Achievement of Middle School Students
25. Clinical Management of Financial Toxicity–Identifying Opportunities through Experiential Insights of Cancer Survivors, Caregivers, and Social Workers
26. Fostering Creativity or Teaching to the Test? Implications of State Testing on the Delivery of Science Instruction
27. The C-terminal domain of A1/Bfl-1 regulates its anti-inflammatory function in human endothelial cells
28. Differences in growth of Canadian children compared to the WHO 2006 Child Growth Standards
29. Encouraging pharmaceutical innovation to meet the needs of both developed and developing countries
30. Guidelines for Health Technologies: Specific Guidance for Oncology Products in Canada
31. Impact of Income on Physical Concerns, Help Seeking, and Unmet Needs of Adult Cancer Survivors
32. Clinical management of financial toxicity - identifying opportunities through experiential insights of cancer survivors, caregivers, and social workers
33. Cost-Effectiveness of Transdermal Nitroglycerin Use for Preterm Labor
34. Linking Intermediate to Final “Real-World” Outcomes: Is Financial Toxicity a Reliable Predictor of Poorer Outcomes in Cancer?
35. The cost and value of cancer medicines in Ontario, Canada
36. Exploring the relationships between income and emotional/practical concerns and help-seeking by older adult cancer survivors: A secondary analysis
37. Additional file 1 of Pragmatic pharmacoeconomic analyses by using post-market adverse drug reaction reports: an illustration using infliximab, adalimumab, and the Canada vigilance adverse reaction database
38. Out‐of‐pocket costs associated with head and neck cancer treatment
39. Relationships between Canadian adult cancer survivors’ annual household income and emotional/practical concerns, help‐seeking and unmet needs
40. Unequal distribution of financial toxicity among people with cancer and its impact on access to care
41. Universal or targeted screening for fetal alcohol exposure: a cost-effectiveness analysis
42. Cancer patients’ perspectives on financial burden in a universal healthcare system: Analysis of qualitative data from participants from 20 provincial cancer centers in Canada
43. Financial and family burden associated with cancer treatment in Ontario, Canada
44. Cost–Utility of Group Versus Individual Acupuncture for Cancer-Related Pain Using Quality-Adjusted Life Years in a Noninferiority Trial
45. Cancer patients’ perspectives on financial burden in a universal healthcare system: Analysis of qualitative data from participants from 20 provincial cancer centers in Canada
46. Experiencing financial toxicity associated with cancer in publicly funded healthcare systems: a systematic review of qualitative studies
47. Relationships between Canadian adult cancer survivors' annual household income and emotional/practical concerns, help‐seeking and unmet needs.
48. Out‐of‐pocket costs associated with head and neck cancer treatment.
49. The Economic Value of a New Insulin Preparation, Humalog® Mix 25™: Measured by a Willingness-To-Pay Approach
50. Correction to: Patient and family financial burden associated with cancer treatment in Canada: a national study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.